INvestigative Kyphoplasty Efficacy and Safety Trial (INKTEST)

椎体后凸成形术功效和安全性研究试验 (INKTEST)

基本信息

  • 批准号:
    10205238
  • 负责人:
  • 金额:
    $ 18.66万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-01 至 2023-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT ABSTRACT The long-term objective of this project is to improve the care of patients suffering from osteoporotic compression fractures, which occurs in up to 700,000 US patients per year. These painful fractures are a leading cause of back pain-related morbidity and mortality. Historically these fractures were treated with bed rest, bracing, and narcotic analgesics. The advent of spine augmentation, i.e., the percutaneous injection of medical cement into painful fractures, in the 1990s has been considered a watershed event in the care of these patients. The procedure, done either as a simple needle infusion (termed “vertebroplasty”) or with temporary balloon inflation (termed “KKyphoplasty”), has been shown in numerous case series to offer remarkable relief of pain. Unblinded randomized controlled trials (RCTs) of both vertebroplasty and Kyphoplasty confirmed these earlier results, showing benefit of spine augmentation over medical therapy. However, four independent, blinded, placebo controlled trials of vertebroplasty no benefit of over a “simulated” procedure without cement infusion. Unlike vertebroplasty, Kyphoplasty has never been evaluated in a blinded trial. In the aftermath of the “sham” vertebroplasty trials, the number of vertebroplasty procedures performed in the US plummeted, while Kyphoplasty procedures have actually increased over time. Numerous investigators have proposed that Kyphoplasty is superior to vertebroplasty, but numerous RCTs comparing the two procedures have shown relative equivalence in outcomes. As such, it remains unknown whether Kyphoplasty would offer benefit over a "simulated" augmentation, where vertebroplasty did not. In this grant application, we will make plans to carry out a future randomized, controlled trial of Kyphoplasty versus a “control intervention,” where Kyphoplasty is simulated but no cement infused. This type of study design will allow us to determine whether the observed benefit of Kyphoplasty is related to the balloon inflation and cement infusion or to other factors that include patient expectation of benefit (i.e., the “placebo effect”).
项目摘要 该项目的长期目的是改善骨质疏松患者的护理 压缩骨折每年最多发生70万名美国患者。这些痛苦的骨折是 背部疼痛相关的发病率和死亡率的主要原因。从历史上看,这些骨折是用床治疗的 休息,支撑和麻醉镇痛药。脊柱增强的冒险,即经皮注入 在1990年代,医疗水泥是痛苦的骨折 患者。该过程是作为简单的针输注(称为“椎体成形术”)或临时进行的。 气球通货膨胀(称为“ kkyphophoptasusty”)在许多病例系列中都显示出来 痛苦。 椎体成形术和脑膜成形术的未盲随机对照试验(RCT)证实了这些试验 结果,显示了脊柱增强的好处,而不是药物治疗。但是,四个独立,盲目, 椎体成形术的安慰剂对照试验没有水泥输注的“模拟”程序的好处。 与椎体成形术不同,在盲试验中从未评估过Kyphopplasty。在“假”之后 椎体成形术试验,在美国执行的椎体成形术程序的数量下降,而 随着时间的推移,脑臂成形术实际上已经增加了。许多调查人员提出 Kyphophopplasty优于椎体成形术,但比较这两个程序的RCT已显示出来 结果的相对等效性。因此,尚不清楚kyphophopphastuse是否会为 “模拟”增强,椎骨成形术没有。 在此赠款申请中,我们将制定计划,以进行未来的随机,对照型脑膜成形术 与“控制干预”相比,在其中模拟了Kyphopplasty,但没有水泥注入。这类研究 设计将使我们能够确定观察到的雌脑成形术的好处是否与气球通胀有关 和水泥输液或其他因素,包括患者对福利的期望(即“安慰剂效应”)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JEFFREY G JARVIK其他文献

JEFFREY G JARVIK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JEFFREY G JARVIK', 18)}}的其他基金

INvestigative Kyphoplasty Efficacy and Safety Trial (INKTEST)
椎体后凸成形术功效和安全性研究试验 (INKTEST)
  • 批准号:
    10473607
  • 财政年份:
    2021
  • 资助金额:
    $ 18.66万
  • 项目类别:
UW Core Center for Clinical Research Administration
华盛顿大学临床研究管理核心中心
  • 批准号:
    9979763
  • 财政年份:
    2017
  • 资助金额:
    $ 18.66万
  • 项目类别:
Admin Core
管理核心
  • 批准号:
    10475474
  • 财政年份:
    2017
  • 资助金额:
    $ 18.66万
  • 项目类别:
UW Core Center for Clinical Research of Musculoskeletal Conditions
威斯康辛大学肌肉骨骼疾病临床研究核心中心
  • 批准号:
    10680529
  • 财政年份:
    2017
  • 资助金额:
    $ 18.66万
  • 项目类别:
Admin Core
管理核心
  • 批准号:
    10680530
  • 财政年份:
    2017
  • 资助金额:
    $ 18.66万
  • 项目类别:
UW Core Center for Clinical Research of Musculoskeletal Conditions
威斯康辛大学肌肉骨骼疾病临床研究核心中心
  • 批准号:
    10475473
  • 财政年份:
    2017
  • 资助金额:
    $ 18.66万
  • 项目类别:
UW Core Center for Clinical Research (CCCR) of Musculoskeletal Conditions
华盛顿大学肌肉骨骼疾病临床研究核心中心 (CCCR)
  • 批准号:
    9979758
  • 财政年份:
    2017
  • 资助金额:
    $ 18.66万
  • 项目类别:
A Pragmatic Trial of Lumbar Image Reporting with Epidemiology (LIRE)
流行病学腰椎影像报告的实用试验 (LIRE)
  • 批准号:
    8987422
  • 财政年份:
    2014
  • 资助金额:
    $ 18.66万
  • 项目类别:
A Pragmatic Trial of Lumbar Image Reporting with Epidemiology (LIRE)
流行病学腰椎影像报告的实用试验 (LIRE)
  • 批准号:
    8774994
  • 财政年份:
    2014
  • 资助金额:
    $ 18.66万
  • 项目类别:
Back pain Outcomes using Longitudinal Data- Extension of Research (BOLDER)
使用纵向数据的背痛结果 - 研究扩展 (BOLDER)
  • 批准号:
    8692115
  • 财政年份:
    2013
  • 资助金额:
    $ 18.66万
  • 项目类别:

相似海外基金

Remote Tai Chi for Knee Osteoarthritis: an Embedded Pragmatic Trial
远程太极拳治疗膝骨关节炎:嵌入式实用试验
  • 批准号:
    10649920
  • 财政年份:
    2023
  • 资助金额:
    $ 18.66万
  • 项目类别:
SUPPORTING WHO ONCHOCERCIASIS ELIMINATION PROGRAMS: PROGRESSING A HIGHLY SENSITIVE AND ULTRA-SPECIFIC RAPID DIAGNOSTIC TEST TO COMMERCIALIZATION READINESS
支持世界卫生组织根除盘尾丝虫病计划:推进高度敏感和超特异性的快速诊断测试以做好商业化准备
  • 批准号:
    10697164
  • 财政年份:
    2023
  • 资助金额:
    $ 18.66万
  • 项目类别:
Leveraging the dyad: mechanisms of an intervention for psychological distress in chronic lung disease
利用二元关系:慢性肺病心理困扰的干预机制
  • 批准号:
    10629648
  • 财政年份:
    2023
  • 资助金额:
    $ 18.66万
  • 项目类别:
Oxysterol-Binding protein like 7 in chronic kidney disease
慢性肾病中的氧甾醇结合蛋白如 7
  • 批准号:
    10603088
  • 财政年份:
    2023
  • 资助金额:
    $ 18.66万
  • 项目类别:
Preventing postpartum depression among immigrant Latinas through a virtual group intervention
通过虚拟团体干预预防拉丁美洲移民产后抑郁症
  • 批准号:
    10503930
  • 财政年份:
    2022
  • 资助金额:
    $ 18.66万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了